Homologous prime-boost vaccination with OVA entrapped in self-adjuvanting archaeosomes induces high numbers of OVA-Specific CD8+ T cells that protect against subcutaneous B16-OVA melanoma

From National Research Council Canada

Download
  1. (PDF, 894 KB)
DOIResolve DOI: https://doi.org/10.3390/vaccines4040044
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleVaccines
ISSN2076-393X
Volume4
Issue4
Pages44
SubjectCD8 T cell response; archaeosome; prime-boost; B16; liposome; tumor vaccine; central memory; effector memory
Abstract
Publication date
LanguageEnglish
Peer reviewedYes
NPARC number23001165
Export citationExport as RIS
Report a correctionReport a correction
Record identifier47ccb66d-22f3-4b57-af88-ccd491e36d86
Record created2016-12-21
Record modified2019-03-08
Date modified: